Skip to content

to study the effect of lavana pinda sweda in manyastambha

A randmized controlled clinical trial to study the effect of lavana pinda sweda in manyastambha with special reference to cervical spondylosis - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072448
Enrollment
60
Registered
2024-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

None listed

Sponsors

Dr Prerana Devidas Gaikwad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical signs and symptoms of Manyastambha like stiffness and pain in the neck region. Patients fulfilling the diagnostic criteria. Patient who will give consent for procedure.

Exclusion criteria

Exclusion criteria: 1)Patients with history of fracture or dislocated of cervical region. 2)Patients with Diabetes and Cardio vascular diseases, traumatic, infective, neoplastic spine. 3)Tuberculosis of spine. 4)Patients having automotive deformities like ankylosing spondylitis,spinal cord abscess,Rheumatoid arthritis as well as congenital structural disorder will be excluded. 5)Traumatic disorders like cervical strain,injuries to intervertebral joints ligaments and muscles,compression factors vertebral process feacture and ruptured disc. Patients with other joints disorder which are not relates to Manyastambha will be excluded.

Design outcomes

Primary

MeasureTime frame
Reduction in sign and symptoms of manyastambha.Timepoint: 7 days

Secondary

MeasureTime frame
Where trial group is more effective than control group.Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Prerana Devidas Gaikwad

SMBT ayurveda college and hospital

vdpramod31@gmail.com9604633832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026